Warren J. Gasper

Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2.

The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation.

Palliation of thoracic malignancies.

Lung transplantation in patients with connective tissue disorders and esophageal dysmotility.

Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization.

Predicting strangulated small bowel obstruction: an old problem revisited.

Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade.

Excellent outcomes of laparoscopic esophagomyotomy for achalasia in patients older than 60 years of age.

Management of infrapopliteal peripheral arterial occlusive disease.

An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.

Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.

A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.

Assessing the anatomic applicability of the multibranched endovascular repair of thoracoabdominal aortic aneurysm technique.

Vein graft failure.

Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.

Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.

Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.

Ferumoxytol enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.